Using the power of the immune system to eliminate cancerous cells has long the been the goal of immuno-oncology. Immune cells naturally recognize, destroy, and remember the abnormal cells within our ...
A new research perspective titled "Targeting GITR in cancer immunotherapy—there is no perfect knowledge" has been published in Oncotarget. In this new perspective, researchers Diwakar Davar and ...
BUFFALO, NY- June 21, 2023 – A new research perspective was published in Oncotarget's Volume 14 on June 19, 2023, entitled, “Targeting GITR in cancer immunotherapy – there is no perfect knowledge.” ...
The safety of oral uracil-tegafur plus leucovorin in the treatment of colorectal cancer in patients with partial DPD deficiency. Background: Glucocorticoid-induced tumor necrosis factor receptor (GITR ...
Inhibrx's technology may offer best-in-class approach for agonist antibodies New program further expands Five Prime's immuno-oncology pipeline and potential for combination therapies SOUTH SAN ...
Brain injury induces acute inflammation, thereby exacerbating poststroke neuronal damage. 1, 2, 3, 4 Although central nervous system (CNS) is known for its limited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results